Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 5/20 | 0.38 |
| ▸ | CTSL | P07711 | 2/20 | 0.38 |
| ▸ | CTSB | P07858 | 2/20 | 0.38 |
| ▸ | CTSS | P25774 | 2/20 | 0.38 |
| ▸ | PSEN1 | P49768 | 5/20 | 0.36 |
| ▸ | PSEN2 | P49810 | 5/20 | 0.36 |
| ▸ | APH1B | Q8WW43 | 5/20 | 0.36 |
| ▸ | NCSTN | Q92542 | 5/20 | 0.36 |
| ▸ | APH1A | Q96BI3 | 5/20 | 0.36 |
| ▸ | PSENEN | Q9NZ42 | 5/20 | 0.36 |
| ▸ | ITGB3 | P05106 | 7/20 | 0.36 |
| ▸ | ITGA2B | P08514 | 7/20 | 0.36 |
| ▸ | ACE | P12821 | 2/20 | 0.36 |
| ▸ | ACE2 | Q9BYF1 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30890737 | 0.91 | PSEN1 (0.41) | CTSKCTSLCTSBCTSSPSEN1 | |
| SCHEMBL30890397 | 0.84 | PSEN1 (0.41) | CTSKCTSLCTSBCTSSPSEN1 | |
| SCHEMBL2456560 | 0.84 | ITGB3 (0.42) | CTSKCTSLCTSBCTSSITGB3 | |
| SCHEMBL6984792 | 0.84 | ITGB3 (0.42) | CTSKCTSLCTSBCTSSITGB3 | |
| SCHEMBL30890639 | 0.80 | ITGB3 (0.38) | ITGB3ITGA2B | |
| SCHEMBL30890666 | 0.80 | ITGB3 (0.38) | ITGB3ITGA2B | |
| SCHEMBL27245117 | 0.80 | CTSK (0.56) | CTSKCTSS | |
| SCHEMBL27245127 | 0.80 | CTSK (0.56) | CTSKCTSS | |
| SCHEMBL1429952 | 0.79 | ITGB3 (0.40) | CTSKCTSLCTSBCTSSITGB3 | |
| SCHEMBL5503179 | 0.79 | CTSK (0.45) | CTSKCTSLCTSBCTSSITGB3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4612156-A1 | ANTI-VIRAL COMPOUNDS | Aligos Therapeutics, Inc. (US) | 2025-09-10 | — | — | EP | disclosed |
| WO-2024097296-A1 | ANTI-VIRAL COMPOUNDS | ALIGOS THERAPEUTICS, INC. (US) | 2024-05-10 | — | — | WO | disclosed |